Member Info for Chrisatrdg

I am sorry fella's but in know way would the EU hold back funds for political reasons.As someone who has dealt with EU organisations on a match funding basis we will receive any due funds when due process has taken place.I will also have to say that we will not be leaving on the 31st October there will be an extension my sources in Brussels tell me they have been thinking of making it 12 months.Finally in my opinion we will never be leaving the EU - sorry to disappoint !!!!!!
With regards the future for INFA the future is good.

I am currently listening to todays presentation in the US which has new slides & introductions to new staff.Summit is clearly on a roll.It is making for a very positive listen.Well done Summit,

The following sentiment could be one of the reasons in the sudden SP increase for which I note further interest on the NASDAQ this evening;
Summit Therapeutics' Upcoming R&D Day Could Be A Tradeable Event:
http://seekingalpha.com/article/4294632-summit-therapeutics-upcoming-r-and-d-day-tradeable-event?dr=1#alt1

InfraStrata posts solid gains as it advances Islandmagee project:
http://www.proactiveinvestors.co.uk/companies/news/903985/infrastrata-posts-solid-gains-as-it-advances-islandmagee-project-903985.html

stew200 - Summ is currently 14.38 % up at $1.75 = £0.29p which is the highest rise this year.I also note that we have not had the interim results out yet for the 6 months ended 31st July 2019 which are normally out by now - is there something brewing ?

I was disappointed not to see at least an update RNS this morning but I am hoping for one this week.To issue an RNS in the last week of September with September completion dates & no update in or near September is not good enough so hopefully we will get one soon .At the weekend I forward sold 300,000 shares at 0.09p as I need some funds hope to reach that point in the next month or so.

Well done dawski37 Glad to see you have added today I made a small addition myself last week of 27,000 shares at 0.45 it all will be worth it hopefully soon.

Summit Therapeutics to Host R&D Day 7 October 2019

https://www.summitplc.com/app/uploads/2019/09/2019_RNS_33-RD-Day-alert-FINAL.pdf

Hi All - Todays update seems to me to knock the Sunday Times article on the head.Onwards & upwards.

http://www.proactiveinvestors.co.uk/companies/news/902119/summit-presents-dds-04-data-at-antibiotic-resistance-conference-902119.html

Summit Therapeutics plc
(‘Summit’ or the ‘Company’)

Summit Therapeutics to Participate in Upcoming Investor Conferences

Oxford, UK, and Cambridge, MA, US, 4 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, announces that management will participate in several upcoming investor conferences taking place in New York City.

9 September 2019 – Janney Healthcare Conference
10 September 2019 – H.C. Wainwright 21st Annual Global Investment Conference, presentation at 12:05pm EDT
23-24 September 2019 – Oppenheimer Fall Summit
A live webcast of the H.C. Wainwright presentation will be available in the Investors section of the Company's website, www.summitplc.com. A replay of the webcast will be available from the same location soon after the live presentation. There will be no podium presentations at the Janney and Oppenheimer conferences.

About Summit Therapeutics
Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers. We are currently developing new mechanism antibiotics for infections caused by C. difficile, N. gonorrhoeae and Enterobacteriaceae and are using our proprietary Discuva Platform to expand our pipeline. For more information, visit www.summitplc.com and follow us on Twitter @summitplc.

It maybe just me but I have not been able to find the presentation from the
Canaccord Genuity Growth Conference & so phoned Summit this afternoon it is a matter of clicking on the title per link below:
https://www.summitplc.com/app/uploads/2019/08/201908_Corporate-Presentation-Aug-Canaccord-final.pdf

Per waterloo01 from the other board this morning:
https://www.dailymail.co.uk/news/article-7409059/Forget-climate-change-antibiotics-crisis-kill-says-NHS-chief.html
NHS chief says that superbugs could kill us before climate change does
Dame Sally Davies warns 10million people could die every year from superbugs
England's chief medical officer says we are 'underinvesting in sorting it out'

Hi All - I have been following the SP the last couple of days to see if it dips below my top ups last week & so far for the first time since my small Buys going back to March it has not.Are we now at the bottom of the SP looking at the latest Buys some people must think so.

I note positive movements this morning in the Buys & the SP may even add a further 25,000 for my wife this morning.Has the worm finally turned - I think so.

InfraStrata plc
@InfraStrata_Plc
·Aug 15
Marine survey works are progressing ahead of schedule, despite the damp and blustery weather.

Well chrishutch - I was not going to say anything but I so agree with you. I did my final top up yesterday morning of 30,000 shares by further reducing my current account buffer & rearranged my finances in the afternoon pre possible Brexit.My rearranged finances gave me a small cash flow advantage so I decided to add a further 270,000 shares taking me to 2m but none of this would have been possible without the help of those who have been part of bringing the SP so low so I thank them.I am still feeling very positive about the 'Good ship INFA' & expect a x2 or x3 increase in the SP this year.Good luck to all long termers.

Per waterloo01 from the other board:
'This is interesting, FDA just approved new antibiotic under limited population pathway. Only 107 in trial. Must really fast track approval. Hopefully for the Gonorrhoea trial?
This approval also marks the second time a drug is being approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs, a pathway, advanced by Congress, to spur development of drugs targeting infections that lack effective therapies.'
http://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs

The current position is dire because of lack of positive news which as we know is the kiss of death for any share on AIM & only encourages shorting of the stock.My challenge to JW is we now need an update RNS if only to tell us that all land has now been secured (I guess it is by now).I will also be tweeting this message to JW this morning.I now have this share as Hold but do have plans to sell one of my old Biotech shares (At great loss) to increase my holding to 2m but not yet.Time to act JW.

InfraStrata plc
@InfraStrata_Plc
·
Aug 1
The Pre Construction Marine Environmental Baseline survey is well underway with various scientific instruments having been deployed off the coastline at Islandmagee this week. #INFA
http://twitter.com/InfraStrata_Plc